The 503B Outsourcing Story

Presented on July 30, 2020

Download our webinar on 503B outsourcing and how they deliver personalized medicine and mitigate drug shortages. 503B quality and operations personnel, Directors of Pharmacy and surgery centers, purchasers, and anyone with an interest in personalized medicines or mitigating drug shortages in FDA-regulated industries. Key takeaways:

• What a pharma industry Section 503B outsourcing facility is
• The role they play in producing personalized medicine products
• How they help mitigate drug shortages
• How they are partnering with industry to provide higher quality clinical trial materials
• A novel application of machine learning with enforcement documents
• How an AI tool can analyze an FDA warning letter and provide additional insight